Share Markets Open Weak; Tata Motors Down 6.9% on Q2 Result

Tue, 15 Nov 09:30 am

   Previous Close   

   Pre-Open   

   11:30 am   

   01:30 pm   

   Closing   

Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.15%, while the Hang Seng is down 0.33%. The Shanghai Composite is not trading. European markets finished higher today with shares in France leading the region. The CAC 40 is up 0.43%, while London's FTSE 100 is up 0.34% and Germany's DAX is up 0.24%.

Indian share markets have opened the day on a weak note amid negative global cues. The BSE Sensex is trading lower by 291 points (down 1%) while the NSE Nifty is trading lower by 94 points (down 1.1%). The BSE Mid Cap index is trading down by 1.6% and BSE Small Cap index is trading lower by 1.9%. The rupee is trading at 67.70 to the US$.

Barring PSU stocks, all the sectoral indices have opened in the red with auto & realty stocks leading the losses.

Tata Motor's share price opened the trading week down by 5.5% as the company's quarterly numbers missed market estimates amid a tussle between Tata group holding company Tata Sons and its former chairman Cyrus Mistry, who was ousted last month.

As per an article in The Economic Times, Lupin Limited has launched Iron Isomaltoside injectable iron formulation under two brand names Isofer and Jilazo in India.

Reportedly, Lupin had acquired the exclusive rights to market and sell the injectable formulation from Denmark-based Pharmacosmos A/S. Further, Iron Isomaltoside 1000 is indicated for the treatment of iron deficiency anemia. It is also used across a wide range of disease states associated with iron deficiency.

Moreover, Lupin will promote both the injectable formulations through its own sales force in India. According to IMS health sales data as on August 2016, the Hematinic market in India is currently worth around Rs 19.3 billion. Out of this, the iron injectable market size is valued at Rs 3.1 billion with growth of 17%.

Notably, the product is currently marketed in 33 countries, including 21 European Union countries under the brand name Monofer. Whether the new launch of these injectables help Lupin widen its footprint in this space will be the key thing to watch out for going ahead

In another development, it was reported that all bulk drug consignments from China are under the scanner of the Drugs Controller General of India because of their poor quality and invalid documents.

Reportedly, out of 2,000 types of API imported in India, more than 60% are from China. Most of the cases of sub-standard drugs, drugs with dubious origin or suspected label are coming from China. The special watch on Chinese imports was initiated in the recent months after the drug regulator found several deviations.

Moving on to the news from stocks in FMCG sector. According to an article in a leading financial daily, Britannia Industries is planning to bring in new products in the bakery segment, to fill gaps in its portfolio. The company is looking at diversification and bakery area is where first diversification is going to be.

In this regard, the company is planning a series of launches and the earliest would be nine to ten months away.

The company is also looking to consolidate its position in the Hindi-heartland and Gujarat. The company is eyeing upping its portfolio in the weaker markets even as it ramps up distribution presence.

While rural sales account for 30% of Britannia's turnover, a good run in the Hindi heartland will help the company achieve its larger target of a 50-50 break-up between urban and rural sales in the next five years.

Meanwhile, Britannia's second-quarter profit rose 5.84% to Rs 2.34 billion from a year ago. Revenue increased 11.2% to Rs 24.30 billion in the three months ended 30 September. Britannia Industries Ltd saw sustained volume growth in the September quarter and also reported a pickup in the biscuits market that augurs well for the future.

The company's base business volume growth rose by 10% in the quarter, maintaining levels seen in the past two quarters. Its consolidated business, which includes the dairy and overseas segments, saw sales grow by 11%, while costs grew by 17.2%, while it's operating profit margin narrowed by 92 basis points.

Britannia's share price opened down by 3.9%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers